Alessandra Spada paper in RSC Appl. Interfaces; for EGFR-overexpressing cancer cells
Congratulations to Alessandra for her paper in RSC Appl. Interfaces! - EPFL
Congratulations to Alessandra for her paper in RSC Appl. Interfaces!
Import & publish the news
Are you sure you want to import this news into ?
This news will be sent to its subscribers.
We are pleased to share that the publication of Alessandra Spada entitled " Orthogonal functionalization of lithium niobate nanoparticles with targeting aptamers and caged chemotherapeutics " has just been published in RSC Appl. Interfaces.
In this study, Alessandra developed othogonal surface functionalization pathways to develop lithium niobate (LNO)-based nanopaltforms displaying both photocaged anticancer drugs and anti-EGFR aptamers for the targeting of cancer cells overexpressing the epidermal growth factor receptor. We are grateful to the team of Prof. Yannick Mugnier (SYMME, University Savoie Mont-Blanc) for providing the bare harmonic LNO nanocrystals.
The study was funded by the Swiss National Science Foundation (DARE, grant N° 200021E_205745) and the French Agence Nationale de la Recherche (DARE, grant N° ANR-21- CE09-0036-01).
Spada, A.; Gheata, A.; Dhouib, A.; Mugnier, Y. Gerber-Lemaire, S. Orthogonal functionalization of lithium niobate nanoparticles with targeting aptamers and caged chemotherapeutics. RSC Appl. Interfaces 2026. DOI: 10.1039
Source: Group for Functionalized Biomaterials
All Group for Functionalized Biomaterials news
All Basic Sciences | SB news